Clinical Trial Update: LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating LX102 in patients with neovascular age-related macular degeneration; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• LX102

Snippet

Sponsor: Innostellar Biotherapeutics Co.,Ltd | Conditions: Neovascular Age-Related Macular Degeneration | Phase 1 | Status: ACTIVE_NOT_RECRUITING